300 results on '"Workman, Creg J."'
Search Results
2. LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity
3. Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity
4. IFNγ-induction of TH1-like regulatory T cells controls antiviral responses
5. Autoreactive CD8+ T cells are restrained by an exhaustion-like program that is maintained by LAG3
6. Neuronally expressed PDL1, not PD1, suppresses acute nociception
7. Therapeutic targeting of regulatory T cells in cancer
8. LAG3 associates with TCR–CD3 complexes and suppresses signaling by driving co-receptor–Lck dissociation
9. Interferon-γ: teammate or opponent in the tumour microenvironment?
10. Cutting Edge: LAG3 Dimerization Is Required for TCR/CD3 Interaction and Inhibition of Antitumor Immunity
11. Regulatory T Cells in the Tumor Microenvironment
12. Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity
13. Lymphocyte‐Activation Gene 3 Facilitates Pathological Tau Neuron‐to‐Neuron Transmission.
14. Integrated BATF transcriptional network regulates suppressive intratumoral regulatory T cells
15. Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion
16. Pathological Tau transmission initiated by binding lymphocyte-activation gene 3
17. Data from Systemic Immune Dysfunction in Cancer Patients Driven by IL6 Induction of LAG3 in Peripheral CD8+ T Cells
18. Supplementary Data from Systemic Immune Dysfunction in Cancer Patients Driven by IL6 Induction of LAG3 in Peripheral CD8+ T Cells
19. Data from Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
20. Supplementary Tables 1-2, Figures 1-11 from Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
21. Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3
22. Epitope Mapping of Therapeutic Antibodies Targeting Human LAG3
23. LAG3 limits regulatory T cell proliferation and function in autoimmune diabetes
24. Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate with favorable outcomes in severe COVID-19
25. Systemic Immune Dysfunction in Cancer Patients Driven by IL6 Induction of LAG3 in Peripheral CD8+ T Cells
26. Molecular Pathways and Mechanisms of LAG3 in Cancer Therapy
27. Interferon Gamma Induction of TH1-like Tregs Controls Anti-viral Responses
28. LAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L
29. People critically ill with COVID-19 exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 lung viral burden
30. Interleukin-35: Structure, Function and Its Impact on Immune-Related Diseases
31. A Cre-driven allele-conditioning line to interrogate CD4+ conventional T cells
32. Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis
33. COVID-19 versus Non–COVID-19 Acute Respiratory Distress Syndrome: Comparison of Demographics, Physiologic Parameters, Inflammatory Biomarkers, and Clinical Outcomes
34. Interferon-γ: teammate or opponent in the tumour microenvironment?
35. The costimulatory activity of Tim-3 requires Akt and MAPK signaling and its recruitment to the immune synapse
36. Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment
37. Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding
38. The development and function of regulatory T cells
39. Aplp1 and the Aplp1-Lag3 Complex facilitates transmission of pathologic α-synuclein
40. Metalloproteases regulate T‐cell proliferation and effector function via LAG‐3
41. The inhibitory cytokine IL-35 contributes to regulatory T-cell function
42. Bifurcated monocyte states are predictive of mortality in severe COVID-19
43. Competition for Active TGFβ Cytokine Allows for Selective Retention of Antigen-Specific Tissue- Resident Memory T Cells in the Epidermal Niche
44. Regulatory T Cell–Derived TRAIL Is Not Required for Peripheral Tolerance
45. Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide–based retroviral vector
46. In Vivo Treg Suppression Assays
47. Modulation of Redox Balance Leaves Murine Diabetogenic TH1 T Cells “LAG-3-ing” Behind
48. Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding
49. Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy
50. Interferon gamma production by regulatory T cells is required for response to cancer immunotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.